deltatrials
Completed NCT00000932

A Study of the Long-Term Outcomes of HIV-Positive Patients

A Prospective Study of Long-Term Clinical, Virologic, and Immunologic Outcomes in HIV-Infected Individuals

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions HIV Infections
Updated 7 times since 2017 Last updated: Apr 14, 2014 Started: Mar 31, 1999 Primary completion: Sep 30, 2006 Completion: Sep 30, 2006

Listed as NCT00000932, this observational or N/A phase trial focuses on HIV Infections and remains completed. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 7 times since 1999, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2024 [monthly]

    Completed

  5. Jun 2018 — Jan 2021 [monthly]

    Completed

▶ Show 2 earlier versions

  1. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

  2. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Mar 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Allergy and Infectious Diseases (NIAID)
Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Baton Rouge, United States, Boston, United States, Boulder, United States, Camden, United States, Chicago, United States, Denver, United States, Detroit, United States, Farmington, United States, Hillsborough, United States, Houston, United States and 24 more location s